+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Changes in Advanced Immunosuppression and Detectable HIV Viremia Among Perinatally HIV-Infected Youth in the Multisite United States HIV Research Network



Changes in Advanced Immunosuppression and Detectable HIV Viremia Among Perinatally HIV-Infected Youth in the Multisite United States HIV Research Network



Journal of the Pediatric Infectious Diseases Society 2(3): 215-223



Due to successful antiretroviral therapy (ART), perinatally human immunodeficiency virus (PHIV)–infected children are reaching adolescence and young adulthood. Adolescence is characterized by factors (eg, increased risk-taking) that may hamper management. We examined PHIV-infected youth in a multisite US cohort, assessing factors associated with changes in advanced immunosuppression and detectable viremia over time. We conducted a retrospective study of 521 PHIV-infected youth, 12 years and older, followed at 16 HIV clinics in the HIV Research Network between 2002 and 2010. We assessed demographic and clinical factors associated with CD4 <200 cells/mm3 and viral load ≥2.60 log10 HIV-1 RNA copies/mL using multivariable logistic regression. Between 2002 and 2010, the median age of PHIV-infected youth in care increased from 14 to 18 years. The proportion prescribed ART increased from 67.4% to 84%, with virologic suppression increasing from 35.5% to 63.0% (P trend < .01). Older age, Black and Hispanic race/ethnicity, and increasing viremia were independently associated with CD4 <200 cells/mm3. Older age, Black race and Hispanic ethnicity were independently associated with higher likelihood of detectable viremia, whereas more recent year of evaluation and being prescribed ART were associated with a lower likelihood. The proportion of PHIV-infected youth on ART has increased. Rates of viremia and advanced immunosuppression have decreased in recent years, but both rates are higher for older PHIV-infected youth. Factors associated with advanced immunosuppression and viremia offer the chance to define strategies to optimize outcomes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036803362

Download citation: RISBibTeXText

PMID: 26619475

DOI: 10.1093/jpids/pit008


Related references

Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth. JAMA Pediatrics 171(5): 450-460, 2017

Absence of detectable viremia in a perinatally HIV-1-infected teenager after discontinuation of antiretroviral therapy. Journal of Allergy and Clinical Immunology 118(2): 324-330, 2006

Factors Associated With Retention Among Non-Perinatally HIV-Infected Youth in the HIV Research Network. Journal of the Pediatric Infectious Diseases Society 5(1): 39-46, 2016

International research on rural youth. Rural youth research in the Federal Republic of Germany. The work of the rural youth section of the Central Institute for Youth Research in the German Democratic Republic. Invisible in the rural landscape: studies of youth in Great Britain. Rural youth research in the United States. The international network of rural youth researchers. Rural Sociologist 2(4): 248-249; 250-254; 255; 256-260; 261-266; 267-268, 1982

Prevalence and interactions of patient-related risks for nonadherence to antiretroviral therapy among perinatally infected youth in the United States. Aids Patient Care and Stds 24(2): 97, 2010

Rates and correlates of antiretroviral therapy use and virologic suppression among perinatally and behaviorally HIV-infected youth linked to care in the United States. Journal of Acquired Immune Deficiency Syndromes 68(2): 169-177, 2015

Predicting Viral Failure in Human Immunodeficiency Virus Perinatally Infected Youth With Persistent Low-Level Viremia on Highly Active Antiretroviral Therapy. Journal of the Pediatric Infectious Diseases Society 8(4): 303-309, 2019

Cytomegalovirus viremia is not a disease in HIV-infected persons with advanced immunosuppression. Journal of Investigative Medicine 48(1): 73A, 2000

CD4+ and viral load outcomes of antiretroviral therapy switch strategies after virologic failure of combination antiretroviral therapy in perinatally HIV-infected youth in the United States. Aids 29(16): 2109-2119, 2015

Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada. Clinical Infectious Diseases 2019:, 2019

Asking only "Did you use a condom?" underestimates the prevalence of unprotected sex among perinatally HIV infected and perinatally exposed but uninfected youth. Journal of Sex Research 51(5): 599-604, 2014

Sexual Health Knowledge in a Sample of Perinatally HIV-infected and Perinatally-exposed Uninfected Youth. Journal of Hiv/Aids and Social Services 14(3): 277-293, 2015

Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth. Journal of Adolescent Health 54(3): 341-349, 2014

Longitudinal Changes in Body Composition by Dual-energy Radiograph Absorptiometry Among Perinatally HIV-infected and HIV-uninfected Youth: Increased Risk of Adiposity Among HIV-infected Female Youth. Pediatric Infectious Disease Journal 37(10): 1002-1007, 2018

Malignancy in perinatally human immunodeficiency virus-infected children in the United States. Pediatric Infectious Disease Journal 24(3): 237-242, 2005